Zambia | Antiretroviral Drugs
Mothers face many challenges during treatment. Knowing more will help them overcome these obstacles and get better care.
Research has uncovered new ways to reduce mother-to-child transmission through breast feeding and brings us even closer to ending pediatric HIV infection. On paper, the path to protecting more babies from HIV looks clear:
In the real world, it's not that easy. Weak health systems, little or no pre- and postnatal care, and a lack of birthing centers in Zambia make providing the most effective treatment regimens to prevent infections for most women and infants incredibly challenging.
Many women may not disclose their HIV status to others -- including a spouse/partner. Many may not be able to afford to come to the clinic regularly for the whole time period required. And many may have difficulty administering antiretroviral drugs to their babies every day for such a long period of time.
The Foundation will be conducting a research study of HIV-positive women who are following the new HIV prevention regimens, such as the extended infant drug Nevirapine to prevent HIV transmission during breastfeeding. Our goal is to:
The knowledge we learn in this study will provide invaluable information for creating future HIV prevention programs designed to work in Zambia - programs that can be replicated in other countries facing similar challenges.